Autoimmune hemolytic anemia: From lab to bedside

Autoimmune hemolytic anemia (AIHA) is not an uncommon clinical disorder and requires advanced, efficient immunohematological and transfusion support. Many AIHA patients have underlying disorder and therefore, it is incumbent upon the clinician to investigate these patients in detail, as the underlyi...

Full description

Bibliographic Details
Main Authors: R K Chaudhary, Sudipta Sekhar Das
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Asian Journal of Transfusion Science
Subjects:
Online Access:http://www.ajts.org/article.asp?issn=0973-6247;year=2014;volume=8;issue=1;spage=5;epage=12;aulast=Chaudhary
_version_ 1818039544640962560
author R K Chaudhary
Sudipta Sekhar Das
author_facet R K Chaudhary
Sudipta Sekhar Das
author_sort R K Chaudhary
collection DOAJ
description Autoimmune hemolytic anemia (AIHA) is not an uncommon clinical disorder and requires advanced, efficient immunohematological and transfusion support. Many AIHA patients have underlying disorder and therefore, it is incumbent upon the clinician to investigate these patients in detail, as the underlying condition can be of a serious nature such as lymphoproliferative disorder or connective tissue disorder. Despite advances in transfusion medicine, simple immunohematological test such as direct antiglobulin test (DAT) still remains the diagnostic hallmark of AIHA. The sensitive gel technology has enabled the immunohematologist not only to diagnose serologically such patients, but also to characterize red cell bound autoantibodies with regard to their class, subclass and titer in a rapid and simplified way. Detailed characterization of autoantibodies is important, as there is a relationship between in vivo hemolysis and strength of DAT; red cell bound multiple immunoglobulins, immunoglobulin G subclass and titer. Transfusing AIHA patient is a challenge to the immunohematologist as it is encountered with difficulties in ABO grouping and cross matching requiring specialized serological tests such as alloadsorption or autoadsorption. At times, it may be almost impossible to find a fully matched unit to transfuse these patients. However, transfusion should not be withheld in a critically ill patient even in the absence of compatible blood. The "best match" or "least incompatible units" can be transfused to such patients under close supervision without any serious side-effects. All blood banks should have the facilities to perform the necessary investigations required to issue "best match" packed red blood cells in AIHA. Specialized techniques such as elution and adsorption, which at times are helpful in enhancing blood safety in AIHA should be established in all transfusion services.
first_indexed 2024-12-10T08:00:19Z
format Article
id doaj.art-0c1d0a17b53e4c77aaffb22121158c37
institution Directory Open Access Journal
issn 0973-6247
1998-3565
language English
last_indexed 2024-12-10T08:00:19Z
publishDate 2014-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Transfusion Science
spelling doaj.art-0c1d0a17b53e4c77aaffb22121158c372022-12-22T01:56:47ZengWolters Kluwer Medknow PublicationsAsian Journal of Transfusion Science0973-62471998-35652014-01-018151210.4103/0973-6247.126681Autoimmune hemolytic anemia: From lab to bedsideR K ChaudharySudipta Sekhar DasAutoimmune hemolytic anemia (AIHA) is not an uncommon clinical disorder and requires advanced, efficient immunohematological and transfusion support. Many AIHA patients have underlying disorder and therefore, it is incumbent upon the clinician to investigate these patients in detail, as the underlying condition can be of a serious nature such as lymphoproliferative disorder or connective tissue disorder. Despite advances in transfusion medicine, simple immunohematological test such as direct antiglobulin test (DAT) still remains the diagnostic hallmark of AIHA. The sensitive gel technology has enabled the immunohematologist not only to diagnose serologically such patients, but also to characterize red cell bound autoantibodies with regard to their class, subclass and titer in a rapid and simplified way. Detailed characterization of autoantibodies is important, as there is a relationship between in vivo hemolysis and strength of DAT; red cell bound multiple immunoglobulins, immunoglobulin G subclass and titer. Transfusing AIHA patient is a challenge to the immunohematologist as it is encountered with difficulties in ABO grouping and cross matching requiring specialized serological tests such as alloadsorption or autoadsorption. At times, it may be almost impossible to find a fully matched unit to transfuse these patients. However, transfusion should not be withheld in a critically ill patient even in the absence of compatible blood. The "best match" or "least incompatible units" can be transfused to such patients under close supervision without any serious side-effects. All blood banks should have the facilities to perform the necessary investigations required to issue "best match" packed red blood cells in AIHA. Specialized techniques such as elution and adsorption, which at times are helpful in enhancing blood safety in AIHA should be established in all transfusion services.http://www.ajts.org/article.asp?issn=0973-6247;year=2014;volume=8;issue=1;spage=5;epage=12;aulast=ChaudharyAlloadsorptionalloantibodyautoadsorptionautoantibodyautoimmune hemolytic anemiabest match bloodflow cytometrygel technology
spellingShingle R K Chaudhary
Sudipta Sekhar Das
Autoimmune hemolytic anemia: From lab to bedside
Asian Journal of Transfusion Science
Alloadsorption
alloantibody
autoadsorption
autoantibody
autoimmune hemolytic anemia
best match blood
flow cytometry
gel technology
title Autoimmune hemolytic anemia: From lab to bedside
title_full Autoimmune hemolytic anemia: From lab to bedside
title_fullStr Autoimmune hemolytic anemia: From lab to bedside
title_full_unstemmed Autoimmune hemolytic anemia: From lab to bedside
title_short Autoimmune hemolytic anemia: From lab to bedside
title_sort autoimmune hemolytic anemia from lab to bedside
topic Alloadsorption
alloantibody
autoadsorption
autoantibody
autoimmune hemolytic anemia
best match blood
flow cytometry
gel technology
url http://www.ajts.org/article.asp?issn=0973-6247;year=2014;volume=8;issue=1;spage=5;epage=12;aulast=Chaudhary
work_keys_str_mv AT rkchaudhary autoimmunehemolyticanemiafromlabtobedside
AT sudiptasekhardas autoimmunehemolyticanemiafromlabtobedside